Passions

Film and music

Rhône Wine

Art and architecture

Experience

Jackpocket Reaches Agreement to Be Acquired by DraftKings for $750 Million

February 15, 2024

Cooley advised Jackpocket, the first licensed third-party lottery courier app in the US, on its definitive agreement to be acquired by DraftKings for $750 million.

Read more

Related contacts

Kevin Cooper
Partner, New York
Jeff Laretto
Partner, New York
Ross Eberly
Partner, Los Angeles Santa Monica
Stephanie Gentile
Partner, New York
Jacqueline Grise
Partner, Washington, DC
Brendan Hughes
Partner, Washington, DC
Len Jacoby
Partner, New York
Phil Mitchell
Partner, New York
Timothy Shapiro
Partner, Palo Alto
Lei Shen
Partner, Chicago
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stacey A. Bradford
Special Counsel, Washington, DC
David Burns
Special Counsel, Washington, DC
Ryan Montgomery
Special Counsel, Boston
Judd Lauter
Special Counsel, San Francisco
Leo Norton
Special Counsel, San Diego
Steve Andersen
Associate, New York
Cara Buchicchio
Associate, New York
David Dalton
Associate, Los Angeles Santa Monica
Erika Freeman
Associate, New York
Amanda Griggs
Associate, New York
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Alexandra Leavy
Associate, New York
Richard G.S. Lee
Associate, Washington, DC
Anisha Mohin
Associate, New York
Pat O'Connell
Associate, New York
Scott D. Rudin
Associate, New York
Yoon Soo (Peter) Shin
Associate, New York
Christine Tse
Associate, New York
Steven A. Zuckerman
Associate, New York
Margie Murphy
Paralegal Specialist, New York
Patricia Myers
Paralegal Specialist, Colorado
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Brii Biosciences Announces Agreements to Acquire VBI Vaccines’ IP Rights in BRII-179

February 14, 2024

Cooley advised Brii Biosciences on its agreements with VBI Vaccines (NASDAQ: VBIV) to ensure expansion and control of future clinical and commercial supplies of BRII-179, a late-stage clinical asset in Brii Bio’s hepatitis B virus functional cure portfolio. With operations in major biotechnology centers in the US and China, Brii Bio (HKSE: 2137) is a Hong Kong Stock Exchange-listed biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Rama Padmanabhan
Partner, San Diego
Rajdeep Roger Bains
Associate, San Diego
Jason Savich
Partner, San Francisco
Lila Hope
Partner, Palo Alto
Michael Klein
Partner, New York
Michelle Garcia Schulman
Partner, Reston
Matthew S. Scarano
Associate, San Diego
Jameson Davis
Associate, Palo Alto
Kaiting Yang
Associate, Hong Kong
Ross Eberly
Partner, Los Angeles Santa Monica
Jeffrey J. Tolin
Partner, New York
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Robert Eisenbach
Of Counsel, San Francisco
Rena Kaminsky
Special Counsel, Palo Alto
Olya Antle
Associate, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Yoni Horn
Associate, Los Angeles Santa Monica
Patrick Sharma
Associate, Los Angeles Santa Monica
Lunga Su
Associate, Shanghai
Yiying Wang
Associate, Shanghai

Related Practices & Industries

Rubicon Technology Partners Announces Strategic Majority Investment in Vimly Benefit Solutions

February 13, 2024

Cooley advised Rubicon Technology Partners – a Boulder, Colorado-based private equity firm focused exclusively on investing in and growing software companies – on its majority strategic investment in Vimly Benefit Solutions, a leader in the benefits administration space.

Read more

Related contacts

Kester Spindler
Partner, Colorado
Grigor Lynch
Associate, Colorado
Andrew Mettry
Associate, Chicago
Baasit Bhutta
Associate, Colorado
Tyler McClure
Associate, San Francisco
Tracy Rubin
Partner, Palo Alto
Steve Flores
Partner, Chicago
Todd Gluth
Partner, San Diego
David Navetta
Partner, Colorado
Tijana Brien
Partner, Palo Alto
Danielle Fortier
Partner, Colorado
Ross Eberly
Partner, Los Angeles Santa Monica
Stacey A. Bradford
Special Counsel, Washington, DC
MaryBeth Shreiner
Special Counsel, Reston
Jennifer Shanley
Special Counsel, New York
Kristopher Kleiner
Special Counsel, Colorado
Calvin Lee
Associate, New York
Tony P. Guan
Associate, Los Angeles Santa Monica
Liz Paisner
Associate, New York
Ehijele Olumese
Associate, Los Angeles Downtown
Joshua Elefant
Associate, Palo Alto
Joshua Elefant
Associate, Palo Alto
Mickeala Tu
Associate, Palo Alto
Allison Kutner
Associate, New York
Chelsea André
Associate, Colorado
Wyatt Kernell
Associate, New York
Margie Murphy
Paralegal Specialist, New York
Patricia Myers
Paralegal Specialist, Colorado

Related Practices & Industries

Gracell Biotechnologies Agrees to Acquisition by AstraZeneca for up to $1.2 Billion

December 26, 2023

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases, on its definitive agreement to be acquired by AstraZeneca.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Izzy Lubarsky
Partner, New York
Brittany K. Wightman
Associate, San Diego
Rajdeep Roger Bains
Associate, San Diego
Melissa Meza
Associate, San Diego
Will Cai
Partner, Hong Kong
Patrick Loofbourrow
Partner, Singapore
Jie Zhang
Partner, Hong Kong
Hilda Li
Associate, Hong Kong
Samantha Zhang
Associate, Singapore
Alessandra Murata
Partner, Palo Alto
Charity Williams
Partner, San Diego
Xander Lee
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Lei Shen
Partner, Chicago
Natasha Leskovsek
Of Counsel, Washington, DC
Rena Kaminsky
Special Counsel, Palo Alto
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Andrew Epstein
Special Counsel, Seattle
Dillon Martinson
Special Counsel, Washington, DC
Ajay Athavale
Associate, San Francisco
Amanda Griggs
Associate, New York
Sara Kim
Associate, Los Angeles Downtown
Patrick Sharma
Associate, Los Angeles Santa Monica
Allison Kutner
Associate, New York
Eileen Leman
Associate, Los Angeles Downtown
Daniel Lac
Associate, San Diego
Sarah Oliai
Associate, Washington, DC

Related Practices & Industries

RayzeBio Signs Approximately $4.1 Billion Acquisition Agreement With Bristol Myers Squibb

December 26, 2023

Cooley advised RayzeBio, a clinical-stage radiopharmaceutical therapeutics (RPT) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs, on its definitive agreement to be acquired by Bristol Myers Squibb.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Rowook Park
Partner, San Diego
Sangitha Palaniappa
Associate, Palo Alto
Caitlin Breitenbruck
Associate, Seattle
Tyler McClure
Associate, San Francisco
Carlos Ramirez
Partner, San Diego
Terren O'Connor
Associate, San Diego
Christine S. Kim
Associate, San Diego
Michelle Hunt
Associate
Marya Postner
Partner, Palo Alto
Carly Robinson
Associate, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Christopher Kimball
Partner, Washington, DC
David Fletcher
Partner, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Eileen Leman
Associate, Los Angeles Downtown
Todd Gluth
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Howard Morse
Partner, Washington, DC
Megan Browdie
Partner, Washington, DC
Nicollette R. Kirby
Associate, Washington, DC

Related Practices & Industries

View more